247 related articles for article (PubMed ID: 31766427)
1. Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells.
Sundaram MK; Unni S; Somvanshi P; Bhardwaj T; Mandal RK; Hussain A; Haque S
Genes (Basel); 2019 Nov; 10(12):. PubMed ID: 31766427
[TBL] [Abstract][Full Text] [Related]
2. Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.
Kedhari Sundaram M; Hussain A; Haque S; Raina R; Afroze N
J Cell Biochem; 2019 Oct; 120(10):18357-18369. PubMed ID: 31172592
[TBL] [Abstract][Full Text] [Related]
3. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
4. Luteolin Causes 5'CpG Demethylation of the Promoters of TSGs and Modulates the Aberrant Histone Modifications, Restoring the Expression of TSGs in Human Cancer Cells.
Pramodh S; Raina R; Hussain A; Bagabir SA; Haque S; Raza ST; Ajmal MR; Behl S; Bhagavatula D
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409426
[TBL] [Abstract][Full Text] [Related]
5. Antineoplastic action of sulforaphane on HeLa cells by modulation of signaling pathways and epigenetic pathways.
Kedhari Sundaram M; Almutary AG; Alsulimani A; Rehan Ahmad S; Somvanshi P; Bhardwaj T; Pellicano R; Fagoonee S; Hussain A; Haque S
Minerva Med; 2021 Dec; 112(6):792-803. PubMed ID: 34114450
[TBL] [Abstract][Full Text] [Related]
6. Chrysin Modulates Aberrant Epigenetic Variations and Hampers Migratory Behavior of Human Cervical (HeLa) Cells.
Raina R; Almutary AG; Bagabir SA; Afroze N; Fagoonee S; Haque S; Hussain A
Front Genet; 2021; 12():768130. PubMed ID: 35096000
[No Abstract] [Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways.
Kedhari Sundaram M; Haque S; Somvanshi P; Bhardwaj T; Hussain A
3 Biotech; 2020 Nov; 10(11):484. PubMed ID: 33117625
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and histone modifications of Wnt genes by genistein during colon cancer development.
Zhang Y; Li Q; Chen H
Carcinogenesis; 2013 Aug; 34(8):1756-63. PubMed ID: 23598468
[TBL] [Abstract][Full Text] [Related]
10. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer.
Majid S; Dar AA; Ahmad AE; Hirata H; Kawakami K; Shahryari V; Saini S; Tanaka Y; Dahiya AV; Khatri G; Dahiya R
Carcinogenesis; 2009 Apr; 30(4):662-70. PubMed ID: 19221000
[TBL] [Abstract][Full Text] [Related]
11. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
12. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells.
Kikuno N; Shiina H; Urakami S; Kawamoto K; Hirata H; Tanaka Y; Majid S; Igawa M; Dahiya R
Int J Cancer; 2008 Aug; 123(3):552-60. PubMed ID: 18431742
[TBL] [Abstract][Full Text] [Related]
13. [DNA methylation and cancer].
Yoshikawa H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):145-9. PubMed ID: 17301518
[TBL] [Abstract][Full Text] [Related]
14. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells.
Zuo Q; Wu R; Xiao X; Yang C; Yang Y; Wang C; Lin L; Kong AN
J Cell Biochem; 2018 Nov; 119(11):9573-9582. PubMed ID: 30129150
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
16. Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes.
Park HJ; Choi YJ; Kim JW; Chun HS; Im I; Yoon S; Han YM; Song CW; Kim H
PLoS One; 2015; 10(7):e0132992. PubMed ID: 26177506
[TBL] [Abstract][Full Text] [Related]
17. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic therapy--a new development in pharmacology.
Peedicayil J
Indian J Med Res; 2006 Jan; 123(1):17-24. PubMed ID: 16567863
[TBL] [Abstract][Full Text] [Related]
19. Genistein, an epigenome modifier during cancer prevention.
Zhang Y; Chen H
Epigenetics; 2011 Jul; 6(7):888-91. PubMed ID: 21610327
[TBL] [Abstract][Full Text] [Related]
20. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
